MTIP AG
VC Fund
Basel, Switzerland
MTIP AG is a VC fund in Basel focused on Health Care and Medical. MTIP is a private equity investor specializing in the healthtech sector.
- Total investments:
- 29
- Last investment:
- Lead investor:
- 59%
- Fund size:
- $250M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries MTIP AG invests in
Stages MTIP AG invests in
Countries MTIP AG invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 7 contacts → | |||
Round size
- Series A
- $1.5M–$36M
- Series B
- $10M–$30M
- Series C
- $9.3M–$80M
Investment Focus
Industry
- Health Care 14 (48%)
- Medical 6 (21%)
- Artificial Intelligence 6 (21%)
- Medical Device 5 (17%)
- Software 4 (14%)
Stage
- Series A 5 (17%)
- Series B 5 (17%)
- Series C 5 (17%)
- Venture - Series Unknown 3 (10%)
- Seed 1 (3%)
Country
- United States 4 (14%)
- United Kingdom 3 (10%)
- Spain 2 (7%)
- France 1 (3%)
- Israel 1 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Christoph Kausch
Managing Partner
|
Managing Partner | Total investments: 9 | Find email | |
Erich Platzer
Healthcare Partner & Member of the Board of Directors
|
Healthcare Partner & Member of the Board of Directors | Total investments: 1 | Find email | |
Felix Grisard
Chairman
|
Chairman | Total investments: 1 | Find email | |
Hans Florian Zeilhofer
Board Member and Co-Founder
|
Board Member and Co-Founder | Total investments: 0 | Find email | |
Marco Gadola
Healthcare Partner
|
Healthcare Partner | Total investments: 1 | Find email | |
| See all 7 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Verifarma
|
Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals. | Private Equity / Mar 30, 2026 | |
TrialBee
|
Trialbee is an independent software company dedicated to deliver solutions and services to the pharmaceutical industry. The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials. | Jan 07, 2026 | |
|
TrialBee
|
Trialbee is an independent software company dedicated to deliver solutions and services to the pharmaceutical industry. The company was founded in 2010 with the development of a method to increase speed and accuracy of patient recruitment to clinical trials. | Jan 07, 2026 | |
NitiNotes
|
Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight. | $9.3M / Series C / Dec 23, 2024 | |
Caresyntax
|
Caresyntax is a digital surgery platform that enables OR teams to predict and improve surgical performance. Its enterprise-grade digital surgery platform delivers insights to improve patient outcomes by using proprietary software and AI to analyze large volumes of video, audio, images, device data, clinical, and operational data in and around theOR.Caresyntax insights help surgeons benchmark and improve their care, hospital administrators use surgical resources more efficiently, medical device companies advance better products, and insurance companies understand risk and devise more tailored policies. The software is used in more than 4,000 operating rooms worldwide, has supported more than 30,000 surgeons, and improved care for more than 2 million patients. | $80M / Series C / Aug 15, 2024 | |
Hexarad
|
Hexarad is a tech-enabled teleradiology that supports the remote reporting of medical scans such as CTs, MRIs and X-rays. | $14.4M / Series B / Aug 15, 2024 | |
|
NitiNotes
|
Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight. | $10.1M / Series B / Sep 25, 2023 | |
Apricity
|
APRICITY is the world's first virtual fertility clinic. It aims at disrupting the fertility treatment experience and at improving chances for women and couples who have difficulties to conceive using data and Artificial Intelligence. The project is led by prominent entrepreneurs, medical practitioners, committed executives and data scientistswith a proven track record. | $16.9M / Series B / Sep 05, 2022 | |
|
Apricity
|
APRICITY is the world's first virtual fertility clinic. It aims at disrupting the fertility treatment experience and at improving chances for women and couples who have difficulties to conceive using data and Artificial Intelligence. The project is led by prominent entrepreneurs, medical practitioners, committed executives and data scientistswith a proven track record. | $16.9M / Series B / Sep 05, 2022 | |
LynxCare
|
LynxCare is an AI-powered Big Data platform. We enable hospitals to mine their legacy data, to improve clinical efficiency and higher the quality of care. | $21.1M / Series A / Jun 21, 2022 | |
| See all 29 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does MTIP AG invest in?
MTIP AG invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Series A and Series B stage. Most of the 29 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is MTIP AG's check size?
MTIP AG typically joins rounds of $1.5M–$36M at Series A, $10M–$30M at Series B and $9.3M–$80M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds MTIP AG participates in.
How do I contact MTIP AG?
Public channels for MTIP AG include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MTIP AG?
The team at MTIP AG includes Christoph Kausch (Managing Partner), Erich Platzer (Healthcare Partner & Member of the Board of Directors) and Felix Grisard (Chairman), among 7 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
